18.96 (-%)
As of Aug 02, 2024
Source:
Morphosys Ag is a commercial-stage biopharmaceutical company devoted to the development and commercialization of innovative therapies for patients, with a focus on cancer. We have a broad pipeline in which we invest in and develop product candidates primarily in the hematology/oncology area. In 2022, we focused on commercializing our marketed product and in advancing product candidates at various stages of development.
Country | Germany |
Headquarters | planegg |
Phone Number | 49 89 89927-0 |
Industry | manufacturing |
CEO | Jean-Paul Kress, M.D. |
Website | www.morphosys.com |